IMBC Spinnova SA

IMBC Spinnova SA is a Belgian private investment firm dedicated to financing spin-offs, spin-outs, and high-tech companies. Established in partnership with the University of Mons (UMons) and Wallonie Entreprendre, the firm focuses on supporting innovative ventures across various high-tech sectors with diverse academic origins. Its financial resources have been steadily increased to support and develop its investment strategy, totaling over €45,000,000.

The firm's investment strategy encompasses direct investments in innovative companies and collaborations with industrial, academic, and financial shareholders in specialized investment funds. Notable partnerships include the Innovation FUND, Digital Attraxion, the VIVES III inter-university investment fund, the AMERIGO stimulus fund, and the Newtree Impact fund. Through these collaborations, IMBC Spinnova has granted 177 equity and quasi-equity investments, amounting to over €60 million, benefiting 101 high-tech companies, spin-offs, spin-outs, and five specialized investment funds.

IMBC Spinnova's portfolio features a diverse range of companies, including D-TEK, a biotech firm specializing in diagnostic kits for autoimmune diseases; Hovertone, known for interactive video mapping; TELIX, an Australian radiopharmaceutical company focused on cancer treatment; Fyteko, specializing in bio-based biostimulants and herbicide bioenhancers; and Sunrise, developing medical devices for sleep apnea diagnosis and therapy. The firm's strategic approach aims to foster innovation and support the growth of high-tech enterprises in Belgium and beyond.